GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Net Margin %

InNexus Biotechnology (InNexus Biotechnology) Net Margin % : 0.00% (As of Mar. 2011)


View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. InNexus Biotechnology's Net Income for the three months ended in Mar. 2011 was $-0.57 Mil. InNexus Biotechnology's Revenue for the three months ended in Mar. 2011 was $0.00 Mil. Therefore, InNexus Biotechnology's net margin for the quarter that ended in Mar. 2011 was 0.00%.

The historical rank and industry rank for InNexus Biotechnology's Net Margin % or its related term are showing as below:


IXSBF's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -152.785
* Ranked among companies with meaningful Net Margin % only.

InNexus Biotechnology Net Margin % Historical Data

The historical data trend for InNexus Biotechnology's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Net Margin % Chart

InNexus Biotechnology Annual Data
Trend Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Jun08 Jun09 Jun10
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,424.39 -34,685.71 -579,200.00 - -

InNexus Biotechnology Quarterly Data
Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of InNexus Biotechnology's Net Margin %

For the Biotechnology subindustry, InNexus Biotechnology's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InNexus Biotechnology's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InNexus Biotechnology's Net Margin % distribution charts can be found below:

* The bar in red indicates where InNexus Biotechnology's Net Margin % falls into.



InNexus Biotechnology Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

InNexus Biotechnology's Net Margin for the fiscal year that ended in Jun. 2010 is calculated as

Net Margin=Net Income (A: Jun. 2010 )/Revenue (A: Jun. 2010 )
=-6.447/0
= %

InNexus Biotechnology's Net Margin for the quarter that ended in Mar. 2011 is calculated as

Net Margin=Net Income (Q: Mar. 2011 )/Revenue (Q: Mar. 2011 )
=-0.569/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InNexus Biotechnology  (GREY:IXSBF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


InNexus Biotechnology Net Margin % Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


InNexus Biotechnology (InNexus Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7
InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines